Determination of BAY 12-8039, a new 8-methoxyquinolone, in human body fluids by high-performance liquid chromatography with fluorescence detection using on-column focusing

Journal of Chromatography B: Biomedical Applications

Volumn 702, Issue 1-2, 1997, Pages 163-174

  Stass, H ^a   Dalhoff, A ^a  

^a BAYER AG   (Germany)

Author keywords

8 Methoxyquinolones; BAY 12 8039

Indexed keywords

8 METHOXYQUINOLONE DERIVATIVE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ARTICLE; BACILLUS SUBTILIS; BIOASSAY; BODY FLUID; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG SALIVA LEVEL; DRUG STABILITY; DRUG STORAGE; DRUG URINE LEVEL; FLUORESCENCE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ADMINISTRATION, ORAL; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BIOLOGICAL ASSAY; BODY FLUIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCADIAN RHYTHM; DRUG STABILITY; FLUOROQUINOLONES; HUMANS; LIGHT; MALE; OSMOLAR CONCENTRATION; QUINOLINES; QUINOLONES; REPRODUCIBILITY OF RESULTS; SALIVA; SPECTROMETRY, FLUORESCENCE; TEMPERATURE; TIME FACTORS;

EID: 0031582884     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(97)00371-X     Document Type: Article

References (30)

1. U. Petersen, A. Dalhoff, R. Endermann, in Proc. of the 36th ICAAC, New Orleans, LA, 1996, F1, p. 100.
2. Dalhoff A., Petersen U., Endermann R. Chemotherapy. 42:1996;410-425.
3. K. Waterbury, J.J. Wang, M. Barbiero, J. Federicici, A.C. Ohlin, E.D. Huguenel, in Proc. of the 36th ICAAC, New Orleans, LA, 1996, F18, p. 103.
4. M.S. Rouse, K.E. Piper, R. Patel, W.R. Wilson, J.M. Steckenberg, in Proc. of the 36th ICAAC, New Orleans, LA, 1996, B45, p. 29.
5. Ch. Kohlsdorfer, BAY 12-8039: Analytical Method Determination in Animal Plasma by HPLC with Fluorescence Detection, Bayer, Wuppertal, 1994, data on file.
6. Schaefer H.-G. J. Chromatogr. 616:1993;87-93.
7. Scholl H., Schmitt K., Weber B. J. Chromatogr. 416:1987;321-330.
8. Lyon D.J., Cheung S.W., Chan C.Y., Cheng A.F. J. Antimicrob. Chemother. 34:1994;446-448.
9. Mizuno A., Uematsu T., Nakashima M. J. Chromatogr. B. 653:1994;187-193.
10. Tan L., Li K. J. Chin. Pharm. Sci. 3:1994;71-75.
11. Pei Y.Y., Meng X., Nightingale C.H. Acta Pharm. Sinica. 15:1994;197-201.
12. Claessens H.A., Kuyken M.A.J. Chromatographia. 23:1987;331-335.
13. Slais K., Kourilova D., Krejci M. J. Chromatogr. 282:1983;363-370.
14. Lin Ling B., Dewaele C., Baeyens W.R.G. J. Microcolumn Sep. 4:1992;17-22.
15. Zeiler H.J., Petersen U., Gau W., Ploschke H.J. Drug Res. 37:1987;131-134.
16. Wingender W., Graefe K.-H., Gau W., Förster D., Beermann D., Schacht P. Eur. J. Clin. Microbiol. 3:1984;355-359.
17. Braggio S., Barnaby R.J., Grossi P., Cugola M. J. Pharm. Biomed. Anal. 14:1996;375-388.
18. Karnes H.T., March C. Pharm. Res. 10:1993;1420-1426.
19. Karnes H.T., Shiu G., Shah V.P. Pharm. Res. 8:1991;421-426.
20. Mehta A.C. Talanta. 34:1987;609-613.
21. E.L. Inman, J.K. Frischmann, P.J. Jimenez, G.D. Winkel, M.L. Persinger, B.S. Rutherford, J. Chromatogr. Sci. 25 (1987) 252-256.
22. FDA, Draft Guideline for Stability Studies for Human Drugs and Biologicals, March 1984.
23. H. Stass, A. Dalhoff, D. Kubitza, in Proc. of the 36th ICAAC, New Orleans, LA, 1996, F-024, p. 104.
24. H. Stass, D. Kubitza, U. Schühly, W. Wingender, in Clinical Microbiol. and Inf., Vol. 3 (Suppl. 2), Laussanne, 1997, P388, p. 87.
25. D. Kubitza, H. Stass, U. Schühly, W. Wingender, in Proc. of the 36th ICAAC, New Orleans, LA, 1996, F-025, p. 104.
26. H. Stass, U. Schühly, W. Wingender, in Clinical Microbiol. and Inf., Vol. 3 (Suppl. 2), Laussanne, 1997, P387, p. 87.
27. H. Stass, K. Ochmann, in Proc. of Int. Congress Chemotherapy, Sydney, 1997, p. 108.
28. H. Stass, D. Kubitza, H.R. Schwietert, J. Wemer, in Proc. of Int. Congress Chemotherapy, Sydney, 1997, p. 108.
29. H. Stass, R. Sachse, in Proc. of Int. Congress Chemotherapy, Sydney, 1997, p. 109.
30. H. Stass, A. Dalhoff, D. Kubitza, in Clinical Microbiol. and Inf., Vol. 3 (Suppl. 2), Laussanne, 1997, P386, p. 86.